Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome
CA 2434035 C · Owner: Naruszewicz, Marek · Inventors: Naruszewicz, Marek; Johansson, Marie-Louise
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention refers to the use of a strain of Lactobacillus in particular Lactobacillus plantarum 299 (DSM 6595) or Lactobacillus plantarum 299 v (DSM 9843), giving to rise or increased amounts of propionic acid or acetic acid in colon for the preparation of a medicament reducing the risk factors involved in the metabolic syndrome, especially increasing the level of HDL cholesterol in serum, and reducing the levels of LDL insulin and leptin, as well as a , high blood pressure.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 12, 2001 and granted June 7, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 12, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 12, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.